Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1253 Records) |
Query Trace: CYP3A4[original query] |
---|
Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine. Journal of clinical pharmacology 2023 12 . Zhipeng Wang, Yuan Gao, Xingfang Ji, Tong Wu, Libin Pu, Wen Q |
Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients. Pharmacogenetics and genomics 2023 12 . Abdel-Hameed Im Ebid, Dina A Ismail, Neama M Lotfy, Mohamed A Mahmoud, Magdy El-Sharka |
[Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study]. Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13. P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev |
CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach. Pharmaceutics 2023 12 15 (12): . Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Josep M Cruzado, Josep M Grinyó, Helena Colom, Nuria Llober |
Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications. Basic & clinical pharmacology & toxicology 2023 12 . Fatemeh Chalabianloo, Lars Thore Fadnes, Kjell Arne Johansson, Gudrun Høiseth, Jørn Henrik Vold, Marianne K Kringen, Olav Spigset, Jørgen G Bramne |
Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China. PloS one 2023 12 18 (12): e0295184. Xiaoqing Jia, Xiaoting Zhang, Tao Zhou, Dalong Sun, Rong Li, Na Yang, Zheng L |
The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism. Biochemical genetics 2023 12 . Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ayman Shawqi Alhazmi, Samah Fathy Ibrahim, Fawwaz Abdul Razaq Al Enazi, Ezzeldeen Hasan Ghanem, Adel Mohammed Binduraih |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis. Psychopharmacology bulletin 2023 12 53 (4): 8-14. A A Parkhomenko, M S Zastrozhin, VYu Skryabin, A E Petukhov, S A Pozdniakov, V A Ivanchenko, I A Zaytsev, I V Bure, P O Bochkov, K A Akmalova, V V Smirnov, E A Bryun, D A Sych |
Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib. Frontiers in pharmacology 2023 12 14 1234262. Bole Li, Shan Liu, Honglei Feng, Chunshuang Du, Liman Wei, Jie Zhang, Guangwei Jia, Chunnuan |
Evaluation of Supervised Machine Learning Algorithms and Computational Structural Validation of Single Nucleotide Polymorphisms Related to Acute Liver Injury with Paracetamol. Current drug metabolism 2023 11 . Kannan Sridharan, Ambritha Balasundaram, Thirumal Kumar D, George Priya Doss |
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. The pharmacogenomics journal 2023 11 . Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Alicia Hamilton, Nury Steuerwald, Lawrence J Druhan, Belinda Avalos, Edward Copelan, Nilanjan Ghosh, Michael R Grunwa |
Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone. Pain reports 2023 11 8 (6): e1113. Samina Ali, Aran Yukseloglu, Colin J Ross, Rhonda J Rosychuk, Amy L Drendel, Robin Manaloor, David W Johnson, Sylvie Le May, Bruce Carlet |
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical pharmacology and therapeutics 2023 11 . Intishar Kazi, Meghan J Chenoweth, Didier Jutras-Aswad, Keith Ahamad, M Eugenia Socias, Bernard Le Foll, Rachel F Tynda |
The Impact of Certain Pharmacogenetic Differences on the Metabolism of Antiretroviral Drugs Used in A Black South African Population. Current drug metabolism 2023 11 . Riaan Reay, Michelle Viljoen, Malie Rheede |
A Physiologically Based Pharmacokinetic Approach to Recommend an Individual Dose of Tacrolimus in Adult Heart Transplant Recipients. Pharmaceutics 2023 11 15 (11): . Ling Pei, Run Li, Hong Zhou, Wenxin Du, Yajie Gu, Yingshuo Jiang, Yongqing Wang, Xin Chen, Jianguo Sun, Junrong Z |
Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism. Transplantation proceedings 2023 10 . Siyu Liang, Xiaoqiu Zhu, Ruiming Cai, Baomei Yan, Weixiang Liang, Mingjin Cai, Pengfeng Ya |
Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus. Pharmacogenomics 2023 10 . Julia Concha, Estela Sangüesa, Jose Luis Peña, María Pilar Ribate, Cristina Belén Garc |
Effect of Isotretinoin on CYP2D6 and CYP3A Activity in Patients with Severe Acne. British journal of clinical pharmacology 2023 10 . Yuqian Zhao, Jay C Vary, Aprajita S Yadav, Lindsay C Czuba, Sara Shum, Jeffrey LaFrance, Weize Huang, Nina Isoherranen, Mary F Hebe |
Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications. Pharmacogenomics 2023 10 . Mohitosh Biswas, Chonlaphat Sukas |
CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients. Scientific reports 2024 4 14 (1): 7922. Hanaa R M Attia, Mahmoud M Kamel, Dina F Ayoub, Shereen H Abd El-Aziz, Mai M Abdel Wahed, Safa N Abd El-Fattah, Mahmoud A Ablel-Monem, Thanaa M Rabah, Amany Helal, Mona Hamed Ibrah |
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 2024 4 25 (7): . Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubia |
Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience. Journal of clinical medicine 2024 4 13 (7): . Corina Andreea Rotarescu, Ion Maruntelu, Ion Rotarescu, Alexandra-Elena Constantinescu, Ileana Constantines |
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio. Nefrologia 2024 4 . Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alex Favà, Josep M Cruzado, Joan Torras, Josep M Grinyó, Nuria Llober |
Impact of Viloxazine Extended-Release Capsules (Qelbree) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical drug investigation 2024 4 . Zhao Wang, Tesfaye Liranso, Zulane Maldonado-Cruz, Alisa R Kosheleff, Azmi Nass |
Identification and Functional Assessment of Eight null Allelic Variants null Detected in the Chinese Han Population. Drug metabolism and disposition: the biological fate of chemicals 2024 1 . Yuying Qi, Hang Yang, Shuanghu Wang, Lili Zou, Fangling Zhao, Qing Zhang, Yun Hong, Qingfeng Luo, Quan Zhou, Peiwu Geng, Hao Chen, Fusui Ji, Jianping Cai, Dapeng D |
Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients. Pharmacogenomics 2024 1 . Teresa T Ho, Janelle B Perkins, Rebecca Gonzalez, James Kevin Hicks, Ronald Alvarez Martinez, Katie Duranceau, Brianna North, Jongphil Kim, Jamie K Teer, Jiqiang Yao, Sean J Yoder, Taiga Nishihori, Nelli Bejanyan, Joseph Pidala, Hany Elmari |
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation. Frontiers in pharmacology 2024 1 14 1334440. Nathan D Seligson, Xunjie Zhang, Mark C Zemanek, Jasmine A Johnson, Zachary VanGundy, Danxin Wang, Mitch A Phelps, Julianna Roddy, Craig C Hofmeister, Junan Li, Ming J P |
The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events. The pharmacogenomics journal 2024 1 24 (1): 3. Amani Abderahmene, Yassine Khalij, Amira Moussa, Meriam Ammar, Amel Ellouz, Dorra Amor, Houwaida Abbes, Mohamed Rayen Ganouni, Wissal Sahtout, Saoussen Chouchene, Asma Omezzine, Dorsaf Zellama, Ali Bousla |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: